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Abstract: 
Unlike other essential trace elements (e.g., zinc and iron) it is the toxicity of manganese (Mn) that is more 
common in human populations than its deficiency. Data suggest alterations in dopamine biology may drive the 
effects associated with Mn neurotoxicity, though recently γ-aminobutyric acid (GABA) has been implicated. In 
addition, iron deficiency (ID), a common nutritional problem, may cause disturbances in neurochemistry by 
facilitating accumulation of Mn in the brain. Previous data from our lab have shown decreased brain tissue 
levels of GABA as well as decreased 
3
H-GABA uptake in synaptosomes as a result of Mn exposure and ID. 
These results indicate a possible increase in the concentration of extracellular GABA due to alterations in 
expression of GABA transport and receptor proteins. In this study weanling-male Sprague–Dawley rats were 
randomly placed into one of four dietary treatment groups: control (CN; 35 mg Fe/kg diet), iron-deficient (ID; 6 
mg Fe/kg diet), CN with Mn supplementation (via the drinking water; 1 g Mn/l) (CNMn), and ID with Mn 
supplementation (IDMn). Using in vivo microdialysis, an increase in extracellular GABA concentrations in the 
striatum was observed in response to Mn exposure and ID although correlational analysis reveals that 
extracellular GABA is related more to extracellular iron levels and not Mn. A diverse effect of Mn exposure 
and ID was observed in the regions examined via Western blot and RT-PCR analysis, with effects on mRNA 
and protein expression of GAT-1, GABAA, and GABAB differing between and within the regions examined. 
For example, Mn exposure reduced GAT-1 protein expression by approximately 50% in the substantia nigra, 
while increasing mRNA expression approximately four-fold, while in the caudate putamen mRNA expression 
was decreased with no effect on protein expression. These data suggest that Mn exposure results in an increase 
in extracellular GABA concentrations via altered expression of transport and receptor proteins, which may be 
the basis of the neurological characteristics of manganism. 
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Article: 
1. Introduction 
Manganese (Mn), an essential nutrient functioning as a critical cofactor for many key enzymes in the body 
(Hurley and Keen, 1987), is required for proper immune function, regulation of metabolism, reproduction, 
digestion, bone growth, and blood clotting (see review by Aschner et al., 2005). However, exposure to high 
concentrations of Mn is known to result in neurotoxicity. Manganese neurotoxicity, or manganism, initially 
characterized by a psychiatric disorder resembling schizophrenia, shares neuro- pathologies with several clinical 
disorders, in particular Parkinson’s disease (Pal et al., 1999). Manganese neurotoxicity is associated with the 
accumulation of Mn in iron-rich, dopaminergic regions of the brain, specifically areas of the basal ganglia 
(Aschner et al., 2005). Manganism is most often associated with occupational exposure of welders, miners, and 
steel workers to chronic high levels of airborne particulate Mn (Pal et al., 1999; Mergler et al., 1994), though 
cases from exposure to contaminated drinking water have been reported as well (Wasserman et al., 2006; 
Kondakis et al., 1989). 
 
Iron deficiency (ID) has become a clear risk factor for Mn accumulation (Davis et al., 1992; Erikson et al., 
2002; Finley, 1999; Kwik-Uribe et al., 2000). A common nutritional problem through-out the world, ID is 
associated with cognitive and behavioral problems (Beard, 2001), potentially disturbing neurochemistry 
by facilitating accumulation of Mn in the brain, as iron (Fe) status is known to affect absorption of Mn, 
regardless of Mn concentrations in the body (Chandra and Shukla, 1976; Shukla et al., 1976). Manganese most 
likely competes with Fe for transport via divalent metal transporter 1 (DMT-1) (Gunshin et al., 1997), a 
transporter of various divalent metals. DMT-1 mRNA expression is known to increase in cases of ID (Gunshin 
et al., 2001; Burdo et al., 1999), and has recently become of interest as a potential transport protein for Mn 
(Garrick et al., 2003; Roth and Garrick, 2003). While most research has focused on the effects of Mn 
neurotoxicity on the metabolism of dopamine (DA) due to locomotor effects, alterations in the metabolism of 
other neurotransmitters, such as γ-aminobutyric acid (GABA), have been noted (Garcia et al., 2006, 2007; Li, 
1998). 
 
GABA is the most abundant inhibitory neurotransmitter in the adult brain (Beleboni et al., 2004; Olsen and 
DeLorey, 1999) and is found in the medium spiny neurons of the striatum, mediating the dopaminergic activity 
in this region (Ade et al., 2008). Cortical glutamate afferents project into the striatum where, in concert with 
GABA and DA, motor behaviors are controlled (Carlsson and Carlsson, 1990). Li (1998) found alterations in 
GABA metabolism during ID, though no absolute changes in GABA concentration were detected. Gwiazda et 
al. (2002) found a significant 16% increase in striatal GABA concentrations resulting from cumulative low-dose 
Mn exposure (14.4mg Mn/kg body weight i.p./ week, over five weeks) in a pre-Parkinsonian rat model. More 
recent studies have shown a significant increase in tissue levels of GABA in rats exposed to a high Mn diet at 
post-natal day 21 (Garcia et al., 2006), but not at earlier time points (Garcia et al., 2007), as well as a marginally 
significant (p < 0.1) decrease in pallidal GABA concentrations in monkeys exposed to MnSO4, with a 20% 
decrease in caudate and putamen of Mn exposed monkeys compared to controls (Struve et al., 2007). Erikson et 
al. (2002) observed an inverse correlation between Mn and GABA concentration in the caudate putamen of ID 
male rats. However, none of these studies examined extracellular levels of GABA, which would reflect what is 
happening at the synaptic level and can be associated with behaviors more relevantly than tissue levels. While 
various microdialysis studies have observed the effect of Mn on extracellular DA concentrations (Vidal et al., 
2005) or the relationship between GABA and DA (Expósito et al., 1999; Galindo et al., 1999), the effect of 
dietary Mn exposure on extracellular GABA concentrations has not been examined. 
 
A recent study by this lab found a significant decrease in 
3
H-GABA uptake correlating with increased Mn 
concentrations and ID in rat striatal synaptosomes (Anderson et al., 2007a), and we hypothesized that this was 
due to altered expression of GABA transporter (GAT-1). It is known that ID affects dopamine transporter 
(DAT) number and function (Erikson et al., 2000), and that it is a member of the solute carrier-6 (SLC-6) 
transporter family like the GAT-1 protein (Gether et al., 2006). The DAT has also been shown to respond to Mn 
and to play a role in Mn transport during toxicity (Anderson et al., 2007b; Erikson et al., 2005; Ingersoll et al., 
1999). Therefore, we hypothesize that increased Mn and/or decreased Fe in the brain will cause decreased 
GAT-1 expression leading to elevated extracellular GABA and overall altered GABA biology, including GABA 
receptors, in the basal ganglia. 
 
In the brain, the inhibitory actions of GABA are mediated by ionotropic GABAA receptors and metabotropic 
GABAB receptors. While GABAA receptors occur post-synaptically, GABAB receptors are present pre-
synaptically as autoreceptors, post-synaptically, and extra-synaptically as heteroreceptors, taking on a more 
neuromodulatory role. Upregulation of peripheral type benzodiazepine receptors in globus pallidus has been 
shown in rats exposed to Mn (Hazell et al., 2003) and in cultured primary rat astrocytes (Hazell et al., 1999). 
Additionally, Mn is known to affect GABA by dose-dependently increasing binding at GABAB receptors (Kerr 
and Ong, 1995). Alterations in neurotransmitter receptor expression can affect expression of transport proteins 
of the respective neurotransmitter via regulation by autoreceptors. This is well characterized in mice lacking 
functional D2 receptors, which consequently experience a significant downregulation of the DAT (Dickinson et 
al., 1999). Similar effects on GAT-1 could be possible through action at GABAB autoreceptors (Zahniser and 
Doolen, 2001). 
Based upon previous data from our lab showing decreased tissue levels of GABA (Erikson et al., 2002) and 
decreased 
3
H-GABA uptake (Anderson et al., 2007a) as a result of dietary Mn exposure and ID, coupled with 
the fact that behaviors associated with Mn neurotoxicity suggest altered GABA metabolism, we hypothesize 
that dietary Mn exposure could potentially lead to an increase in the concentration of extracellular GABA, most 
likely as a result of altered GABA transporter and/or receptor expression. To test this hypothesis, we developed 
this study: (1) to establish alterations in the neuromodulatory extracellular concentrations of GABA in response 
to dietary Mn exposure and ID; (2) to examine alterations in the protein and mRNA expression of the transport 
and receptor proteins of GABA resulting from dietary Mn exposure and ID. 
 
2. Materials and methods  
2. 1. Animals 
Male 21-day-old Sprague–Dawley rats (Harlan Sprague– Dawley, Indianapolis, IN) (n = 24 for the 
microdialysis studies; n = 24 for protein and mRNA analysis) were randomly divided into four dietary treatment 
groups as in previous studies (Anderson et al., 2007a,b): control (CN; 35 mg Fe/kg, 10 mg Mn/kg diet & d.i. 
water); control Mn-exposed (CNMn; control diet & 1 g Mn (as MnCl2)/l d.i. water); iron-deficient (ID; 4 mg 
Fe/kg, 10 mg Mn/kg diet & d.i. water); and iron-deficient/Mn exposed (IDMn; ID diet & 1 g Mn/l d.i. water). 
Diets were obtained from Bio-Serv (French-town, NJ) and certified for metal content. Rats had free access to 
food and water 24 h/day, and the lights were turned off between 1800 and 600 h. Room temperature was 
maintained at 25 ± 1 °C. The University of North Carolina at Greensboro Animal Care and Use Committee 
approved all of the animal procedures. 
 
2.2. Stereotaxic surgery 
After five weeks of dietary treatment and one week prior to microdialysis experiments, rats were anesthetized 
with ketamine-HCl (80 mg/kg) and xylazine (12 mg/kg) and maintained on a heating pad at 37 °C. The heads of 
the rats were shaved and wiped with a 5% povidone-iodine solution to reduce risk of infection. Sterile 
instruments and gloves were used throughout the surgical procedure. The rats were secured in the stereotaxic 
frame and an incision was made perpendicular to the bregma. A guide cannula (CMA/12, CMA Microdialysis, 
Acton, MA) was implanted into the striatum using the following coordinates: 2.4 mm lateral to midline, 7.5 mm 
anterior to the lambda. The cannula was lowered to a depth of 2.5 mm, positioning it in the medial area of the 
striatum (Paxinos and Watson, 1998). Anchoring screws were utilized to maintain the position of the cannula 
before being cemented into place using dental adhesive. Animals were given 0.9% sterile saline (0.5 ml/kg body 
weight, i.p.) to reduce fluid lost while under anesthesia and to aid in recovery time. Animals were returned to 
shoebox cages with Tek-Fresh bedding (Harlan, Indianapolis, IN) and monitored daily until microdialysis 
experiments began. 
 
2.3. Microdialysis 
During week six of the dietary protocol, a microdialysis probe (CMA/12 Elite, CMA Microdialysis, Acton, 
MA) was inserted into the guide cannula and the rat perfused with artificial CSF (155 mM Na
+
, 0.83 mM 
Mg
2+
,2.9 mM K
+
, 132.76 mM Cl
-
, 1.1 mM Ca
+
, pH 7.4) for 1 h at a flow rate of 1 μl/min. After perfusion, the 
flow rate was adjusted to 0.5 μl/min and 30 min fractions were collected in microtubes for a total of 2 h (4 
samples per rat) in a refrigerated fraction collector (CMA Microdialysis, Acton, MA). Samples were stored at    
-80 °C until analysis of the dialysate fraction. To quantify levels of GABA from the microdialysate, fractions 
were analyzed for GABA content using capillary electrophoresis with laser induced fluorescence detection (CE-
LIF) (Biorad Biofocus 2000, Hercules, CA, with 488 nm diode laser/590 nm emission filter). Rats were then 
returned to their home cage and, the following day, were sacrificed, brains removed, and probe placement 
verified post mortem. Brains were dissected into five regions (caudate putamen, globus pallidus, substantia 
nigra, hippocampus, and cerebellum) for metal, protein, and mRNA analyses (see below). Regions were 
selected based on the known heterogeneous accumulation of metals in response to alterations in dietary Fe and 
Mn levels (Anderson et al., 2007a,b; Erikson et al., 2002) and the density of GABAergic neurons. 
 
 
 
2.4. CE-LIF analysis 
A protocol by Chen et al. (2001) allowing for detection of amino acids and biogenic amines at nanomolar 
concentrations was modified to accommodate the needs of this study. The advantages of applying CE analysis 
to neuroactive compounds include minimal required sample volumes, speed of analysis, and high separation 
efficiency (Powell and Ewing, 2005). Briefly, on the day of sample analysis, 5 μl of microdialysate sample were 
derivatized at 40 °C by the addition to 100 nmol ATTO-TAGTM FQ fluorogenic reagent (Molecular Probes, 
Eugene, OR) and 10 μl of a 10 mM borate (Fisher, Fair Lawn, NJ)/25 mM KCN (Fluka) solution (pH 9.18). 
The total sample volume was adjusted to 20 μl using HPLC grade methanol (G.J. Chemical Company, Newark, 
NJ). After a minimum reaction time of 90 min, 1 μl of an FQ derivatized homoserine (Sigma, St. Louis, MO) 
internal standard solution was added to the derivatized microdialysate sample and analyzed. CE-LIF conditions 
leading to high efficiency peaks for GABA samples were 10 kV for 10 min with sample injections at 10 psi/s. 
Uncoated silica capillary (Polymicro, Arizona) with an i.d. of 25 μm, o.d. of 361 μm, and effective/total lengths 
of 25.4/30.0 cm was used. The run buffer was 15 mM sodium borate (Fisher), pH 9.0, with 45 mM sodium 
dodecyl sulfate (Pierce, Rockford, IL), 5 mM sodium cholate (Anatrace, Maumee, OH), and 4% (v/v) 2-
propanol (Fisher). Three replicates were analyzed for each sample, with a calibration curve for GABA 
constructed each day of sample analysis using three points with a concentration range of 50 nM to 1 μM 
GABA. GABA (Sigma) and homoserine standard solutions used for construction of calibration curves were 
prepared in artificial cerebral spinal fluid with the same composition as that used in the microdialysis studies. A 
representative limit of detection for this method is 6.9 nM GABA (based on 3σ, where σ represents the standard 
deviation of the background) with a linear dynamic range of 3.64 decades. The ratio of GABA peak height to 
homoserine peak height for each sample was used to determine the concentration of GABA based on the 
calibration curve response. 
 
2.5. Metal analysis 
Tissue Mn and Fe concentrations were measured with graphite furnace atomic absorption spectroscopy (Varian 
AA240, Varian, Inc., USA). Blood samples were collected at the end of the experiment into heparinized tubes, 
cooled to 4 °C, and centrifuged in a clinical centrifuge for 15 min to separate cells from plasma. Plasma was 
frozen at -80 °C until analyzed for Mn and Fe. Equal volumes of plasma and 0.5% Triton-X were vortexed for 
30 s before being centrifuged at 12,000 x g for 10 min. The supernatant was removed and an aliquot of 50 μl 
brought to 1 ml total volume in 2% nitric acid and analyzed for Mn and Fe content. Brain regions were digested 
in ultra-pure nitric acid (1: 10, w/v dilution) for 48–72 h in a sand bath (60 °C). An aliquot of 50 μl of digested 
tissue was brought to 1 ml total volume with 2% nitric acid and analyzed for Mn and Fe. Microdialysate 
samples were pooled from individual animals and diluted (1:2 dilution in 2% nitric acid) to a final volume of 60 
μl prior to metal analysis. Bovine liver (NBS Standard Reference Material, USDC, Washington, DC) (10 μg 
Mn/g; 184 μg Fe/g) was digested in ultrapure nitric acid and used as an internal standard for analysis (final 
concentration 5 μg Mn/l; 92 μg Fe/l). 
 
2.6. Protein extraction 
Protein was extracted from the brain tissue samples for Western blot analysis from animals that did not undergo 
surgery to ensure no changes in expression due to surgery. Tissue samples were sonicated in 500 μl of RIPA 
lysis buffer (1% Nonidet 40, 1% SDS, 0.5% sodium deoxycholate, 1 mM NaF, 2 mM β-glycerolphosphate, 1 
mM sodium orthovanadate, and 1 x protease inhibitor cocktail (Sigma, St. Louis, MO) in 1 x PBS) on ice until 
completely homogenized. Homogenates were incubated on ice for 20 min before being centrifuged at 12,000 x 
g for 2 0 min at 4 °C. Supernatant was then transferred to new tubes and total protein concentration determined 
by BCA assay (Pierce, Rockford, IL) before proceeding with Western analysis. 
 
2.7. Western blot analysis 
Western blot analysis was conducted to examine the effects of the dietary treatment on expression of GAT-1, 
GABAA, and GABAB proteins in vivo. Protein samples (20 μg) were combined with 4 x LDS sample buffer 
(Invitrogen, Carlsbad, CA) containing 5% β-mercaptoethanol and heated at 70 °C in a heat block for 10 min. 
Samples were then loaded onto a 4–12% Bis-Tris pre-cast mini gel (Invitrogen, Carlsbad, CA) and 
electrophoretically separated under denaturing conditions in 1 x MOPS buffer containing 1% antioxidant 
(Invitrogen, Carlsbad, CA). Proteins were transferred to a PVDF membrane (Millipore, Billerica, MA) before 
blocking with 5% BSA. Membranes were probed overnight at 4 °C with primary antibody (mouse monoclonal 
anti-β-actin, Santa Cruz Biotech, Santa Cruz, CA) (rabbit polyclonal anti-GABAB(R2) subunit; rabbit polyclonal 
anti-GAT-1, C-terminus; rabbit poly-clonal anti-GABAA(α1); Chemicon, Temecula, CA) for the protein of 
interest in 5% BSA. Membranes were rinsed in 1 x TBST (10 mM Tris, pH 7.4,150 mM NaCl, 0.05% Tween 
20) and probed for 2 h at room temperature with an HRP-conjugated secondary antibody (goat anti-rabbit, 
Chemicon, Temecula, CA) (goat anti-mouse, Santa Cruz Biotech, Santa Cruz, CA) in 5% BSA. Membranes 
were then rinsed several times in 1 x TBST before incubation in ECL solution (PerkinElmer, Waltham, MA) 
and exposure to radio-graphic film (Pierce, Rockford, IL). Membranes were also probed for β-actin to verify 
equal loading and for image analysis. This housekeeping protein was chosen for comparison over GAPDH, 
which has been shown to be affected by Mn concentrations (Hazell, 2002). Films were analyzed using image 
analysis software (Image J, NIH, Bethesda, MD), with the amount of the target protein from each sample 
standardized to the amount of β-actin from the sample. 
 
2.8. RNA isolation and cDNA synthesis 
Total RNA was isolated from brain regions for quantitative PCR analysis from animals that did not undergo 
surgery to ensure no changes in mRNA expression as a result of surgery. Tissue samples were stored in 1 ml of 
RNAlater® solution (Ambion Inc., Austin, TX) and stored at —20 °C until analysis. Total RNA was isolated 
utilizing the ToTALLY RNATM kit (Ambion Inc., Austin, TX) following manufacturer’s instructions. RNA 
concentration and purity were determined by spectrophotometric analysis before carrying out cDNA synthesis. 
Synthesis of cDNA from total RNA was performed using the High Capacity cDNA Reverse Transcriptase Kit 
(Applied Biosystems, Foster City, CA) following manufacturer’s instructions. 
 
2.9. Quantitative PCR 
Quantitative real-time PCR analysis was utilized to determine expression of GAT-1, GABAA, and GABAB. 
Triplicate aliquots of cDNA were analyzed on 96-well plates using expression assays for the genes of interest 
obtained from Applied Biosystems (Foster City, CA). Values of cDNA expression were normalized relative to 
the expression of β-actin analyzed from the same sample on the same plate and reported as percent of control. 
 
2.10. Statistical analysis 
Statistical analyses were conducted using SPSS v14. Data were examined for normality of distribution using a 
one-sample Kolmogorov-Smirnov test and presence of outliers by boxplot analysis. Data were analyzed using 
analysis of variance, with Dunnett’s post hoc analysis conducted to assess difference from controls when p < 
0.05. Pearson’s correlational analyses were conducted to examine relationships between extracellular 
concentrations of GABA, Mn, and Fe. 
 
3. Results  
3.1. Microdialysis analysis 
GABA concentrations were increased in CNMn and ID versus CN (Fig. 1A). For analysis, we excluded the 
IDMn group because only two animals survived surgery. Though the difference in GABA concentrations was 
not statistically significant (p = 0.06), the observation does denote an obvious biological response to the dietary 
protocol. Concentrations of Mn in dialysate samples were significantly increased (p < 0.001) in CNMn and ID 
versus CN (Fig. 1B). No correlation was found between the extracellular concentrations of GABA and Mn (data 
not shown). Concentrations of Fe in dialysate samples were significantly decreased (p = 0.023) in CNMn and 
ID versus CN (Fig. 1C). An inverse correlation was observed between the extracellular concentrations of 
GABA and Fe, with GABA concentrations decreasing with increased Fe (Fig. 1C, inset), though the correlation 
was not statistically significant (p = 0.08). Being that there is a trend towards significance (p < 0. 10), it does 
suggest an effect of Fe levels on extracellular GABA concentrations. The statistical significance of this 
experiment is most likely affected by the small sample size. Only two animals from the IDMn group survived 
the surgery, with microdialysis samples being collected. Of the other three treatment groups, samples were 
collected from four out of the six animals. This is not uncommon given the 50% success rate associated with 
this procedure (Nelson et al., 1997), due either to animals succumbing to surgery or removing the cannula 
before sample collection. 
 
3.2. Plasma manganese and iron 
Plasma Mn concentrations were significantly increased in those animals receiving Mn supplementation versus 
those animals receiving deionized water alone (Fig. 2A) (p = 0.02). A significant decrease in plasma Fe 
concentrations was observed in animals receiving the ID diet versus the CN diet (Fig. 2B) (p = 0.007). 
 
3.3. Brain manganese and iron 
In all brain regions, Mn concentration was significantly increased in the Mn-exposure group versus those 
animals that did not receive Mn supplementation (Fig. 3A) (p < 0.05). A heterogeneous response was observed 
in the brain in regard to Fe levels, with a general decrease in Fe concentration in those animals receiving the ID 
diet versus animals receiving the CN diet, though the only significant decrease was seen in the globus pallidus 
(Fig. 3B) (p < 0.05). 
 
3.4. Western blot analysis 
Elevated brain Mn and ID caused an approximate 50% decrease in GAT-1 protein expression in both the 
hippocampus and substantia nigra (Fig. 4A). In the hippocampus, GAT-1 protein expression was significantly 
decreased in CNMn (41%) and ID (47%) versus CN (p < 0.05). Similarly, in the substantia nigra, there was a 
significant decrease in expression of GAT-1 in CNMn (68%), ID (48%), and IDMn (44%) versus CN (p = 
0.03). No significant change in GAT-1 protein expression was observed in the globus pallidus, caudate 
putamen, or cerebellum. The dietary treatment had no effect on β-actin protein levels. Representative blots for 
GAT-1 and β-actin for each region are shown in Fig. 4C, with each band representing an individual animal. 
 
 
Increased Mn and ID were associated with a significant increase in protein expression of GABAA in globus 
pallidus (CNMn 75%; ID 300%; IDMn 300%; p = 0.012) and substantia nigra (ID 200%; IDMn 200%; p = 
0.045) versus CN (Fig. 5A). GABAA expression was significantly increased in hippocampus in CNMn (72%) 
versus CN (p = 0.03) (Fig. 5A). No significant difference in GABAA protein expression was observed in 
caudate putamen or cerebellum. Representative blots for GABAA and β-actin for each region are shown in Fig. 
5C, with each band representing an individual animal. 
 
Iron deficiency and Mn exposure were associated with a decrease in GABAB protein in globus pallidus (IDMn 
46%; p = 0.03), substantia nigra (ID 41%; IDMn 54%; p = 0.02), and hippocampus (ID 70%; IDMn 55%; p = 
0.027) (Fig. 6A). No significant change in GABAB protein expression was observed in caudate putamen or 
cerebellum. Representative blots for GABAB and β-actin for each region are shown in Fig. 6C, with each band 
representing an individual animal. 
 
3.5. Quantitative PCR analysis 
Increased Mn significantly decreased mRNA expression of GAT-1 in the hippocampus (CNMn 52%; IDMn 
67%; p = 0.023) and caudate putamen (IDMn 54%; p = 0.020) (Fig. 4B). In the substantia nigra, mRNA 
expression of GAT-1 was significantly increased three-fold in ID and over five-fold in IDMn versus CN (p = 
0.003) (Fig. 4B). A two-fold increase in GAT-1 expression was observed in the globus pallidus in the Mn-
exposed groups versus CN (Fig. 4B). This increase, though not statistically significant (p = 0.080), does indicate 
a physiological response to the presence of Mn. The dietary treatment had no effect on β-actin mRNA levels. 
 
In substantia nigra, GABAA mRNA expression was significantly decreased in CNMn (67%) and ID (64%) 
versus CN (p = 0.006) (Fig. 5B). No significant changes in mRNA expression of GABAA were observed in any 
of the other regions analyzed (Fig. 5B). Expression of GABAB receptor mRNA was significantly decreased in 
the hippocampus (CNMn 59%; ID 45%; IDMn 43%; p = 0.04), substantia nigra (CNMn 92%; ID 90%; IDMn 
94%; p < 0.001) and caudate putamen (CNMn 55%; IDMn 57%; p = 0.003) versus CN (Fig. 6B). No significant 
changes in mRNA expression were observed in globus pallidus, substantia nigra, or cerebellum. 
 
4. Discussion 
We report for the first time that increased dietary Mn (via drinking water; 100 times more concentrated than in 
the diet) causes elevated extracellular GABA and altered expression of GABA receptors and transporters, at 
both the protein and mRNA level. Extracellular GABA concentrations increased in response to Mn exposure 
and the ID diet (Fig. 1A). Correlational analyses revealed an inverse correlation between extracellular GABA 
and Fe concentrations (Fig. 1C, inset) with no correlation between extracellular GABA and Mn, suggesting 
GABA concentrations are altered as a result of the lowered extracellular Fe caused by Mn exposure and the ID 
diet. In addition, dietary Mn exposure was shown to alter expression of GABA receptor and transport proteins 
and mRNA in vivo, with a varied effect observed across the brain regions examined (Figs. 4–6). These data 
suggest that altered tissue levels of GABA (Erikson et al., 2002) and decreased uptake of GABA (Anderson et 
al., 2007a) due to Mn exposure may be the result of altered expression of its transport protein resulting in 
elevated extracellular GABA concentrations. 
 
As in earlier studies (Anderson et al., 2007a,b), our dietary protocol led to perturbations in systemic levels of 
Mn and Fe. The addition of Mn in the drinking water significantly increased the levels of Mn in the plasma 
(Fig. 2A), while the ID diet lowered the plasma concentration of Fe (Fig. 2B). In the brain, Mn accumulated in 
a diverse fashion across the regions examined, with increased levels of Mn found in those animals receiving Mn 
supplementation via the drinking water (Fig. 3A). In general, Fe was depleted in those animals receiving the ID 
diet; however, the only statistical difference in Fe levels in the brain was observed in the globus pallidus (Fig. 
3B) similar to a previous study from our lab (Erikson et al., 2004). This varied response in Fe levels was 
observed in our previous studies, at both four weeks (Anderson et al., 2007b) and six weeks (Anderson et al., 
2007a) of dietary treatment, with Fe levels varying between and within regions. Additionally, when examining 
the Fe:Mn ratio in the brain, a reduction in brain Fe levels in these animals is apparent, with the ID diet causing 
a significant reduction in the Fe:Mn ratio in most regions (data not shown). 
 
 
 
 
Extracellular GABA concentrations in the caudate putamen were increased in response to Mn exposure and ID 
(Fig. 1A); and while this difference was not statistically significant (p = 0.06), it does indicate a significant 
physiological response to changes in regional metal levels (e.g., high Mn = 3-fold increase; low Fe = 4- fold 
increase compared to CN). An important question arose from these findings; is the elevated GABA due to 
increased extracellular Mn or decreased extracellular Fe? To answer this question, we measured both Mn and 
Fe concentrations in the microdialysis samples and correlated them with the GABA concentrations. Manganese 
levels were significantly increased in those animals receiving Mn supplementation and the ID diet (Fig. 1B); 
however, no correlation was found between extracellular Mn and GABA concentrations, contrary to our 
original hypothesis. Concentrations of extracellular Fe were significantly decreased in those animals receiving 
the ID diet as well as in the CNMn animals versus CN (Fig. 1 C). This finding is interesting given that plasma 
Fe levels in the CNMn animals were normal. However, the Fe found in the plasma represents a more labile pool 
than that found in the CSF. An inverse correlation between extracellular GABA and Fe concentrations was also 
observed, with GABA concentration increasing with decreased Fe, suggesting that decreased Fe (due to both 
dietary deficiency and Mn-exposure) affects the levels of extracellular GABA. Iron deficiency affects GABA 
synthesis via glutamate decarboxylase (GAD) (Li, 1998) and a reduction in GABA brain tissue concentrations 
has been shown in rats fed a marginally ID diet for eight weeks (Shukla et al., 1989). Low tissue 
neurotransmitter levels may be the result of decreased uptake of the respective neurotransmitter (Gainetdinov et 
al., 1998), increasing the extracellular concentrations, a scenario which might be occurring in the current study. 
 
The observed increase in extracellular GABA concentrations could potentially mediate the locomotor effects 
seen in Mn neurotoxicity, such as hyperkinesia, ataxia, and dystonia. GABAergic neurons in the striatum 
receive dopaminergic terminals from the substantia nigra (Smith and Bolam, 1990), in turn modulating the 
dopaminergic functioning in the striatum (Galindo et al., 1999). Increased extracellular levels of GABA in the 
striatum could affect the activity of the GABA projection neurons to the substantia nigra (Koós and Tepper, 
1999), leading to dysregulation of striatal DA release via the nigrostriatal pathway and increased inhibition, 
causing hypokinetic activity, a hallmark of Mn neurotoxicity (Fig. 7). Normandin et al. (2004) observed 
decreases in locomotor activity in Mn-exposed young adult rats, while motor deficits were also observed in a 
study utilizing a pre-Parkinsonian rat model and cumulative low-dose Mn exposure (Gwiazda et al., 2002). In 
both of these studies, DA was not altered, suggesting that changes in GABA may precede and facilitate changes 
in DA during manganism. 
 
A major component of our hypothesis is that increased extracellular GABA due to Mn-exposure is caused by 
alterations in GAT-1. While protein expression of GAT-1 was not decreased in caudate putamen, mRNA 
expression was decreased (Fig. 4B), indicating modulation of GAT-1 and a possible transition occurring in that 
region. Expression of GAT-1 mRNA was significantly decreased in hippocampus as well, while a two-fold 
increase was observed in the globus pallidus and a three and five-fold increase observed in substantia nigra (Fig. 
4B). While the two-fold increase in GAT-1 mRNA expression in globus pallidus was not statistically significant 
(p = 0.08), it does indicate a physiological response to the dietary protocol within this region, perhaps as a 
mechanism to maintain adequate levels of GAT-1 protein. It should be noted that the current results were 
obtained after six weeks of dietary treatment. However, this represents only a snapshot of the modification 
occurring in the globus pallidus over the course of the treatment period as a result of increased Mn. Protein 
levels of GAT-1 in the globus pallidus may have been attenuated earlier than six weeks, with the increases in 
mRNA observed at six weeks the result of a compensatory mechanism. In our previous study, decreases in 
3
H-
GABA uptake were observed after four weeks of dietary treatment in relation to Fe levels (Anderson et al., 
2007a), indicating the likelihood of perturbations in GAT-1 at an earlier time. The increase seen in mRNA 
expression of GAT-1 in substantia nigra as a result of Mn exposure could potentially be a physiological 
response to compensate for decreases in GAT-1 protein in that region by increasing transcription. These 
changes in GAT-1 expression in the substantia nigra and globus pallidus could affect extracellular 
concentrations of GABA in the caudate putamen via nigrostriatal projections (Fig. 7). 
 
 
 
Decreased protein expression of GAT-1 in hippocampus and substantia nigra may also be the result of protein 
degradation and recycling via protein kinase C (PKC). Protein kinase C is known to regulate GAT-1 via 
phosphorylation (Mandela and Ordway, 2006), causing internalization of these proteins, degradation, and 
recycling (Gadea and López-Colomé,2001). An acute Mn treatment (300 μM) has been shown to activate 
caspase-3 leading to activation of PKCδ in N27 mesenchephalic cells (Latchoumycandane et al., 2005). A 
similar response was seen in those cells incubated for 72 h with a lower dose of Mn (50 μM), replicating 
chronic exposure. This 300 μM dose represents a physiologically relevant dose similar to that achieved in the 
current study. Additionally, expression of GAT-1 may be inhibited through effects on pre-synaptic GABAB 
autoreceptors, which can play a part in regulating expression of GAT-1 (Zahniser and Doolen, 2001). Decreases 
in these GABAB autoreceptors could result in a general decrease of GAT-1 density in that region. 
 
As anticipated, GABAB protein expression was significantly decreased in globus pallidus, substantia nigra, and 
hippocampus in those animals receiving the ID diet and Mn supplementation (Fig. 6A). Additionally, 
expression of GABAB mRNA was attenuated in the hippocampus, substantia nigra, and caudate putamen of the 
same animals (Fig. 6B). While Mn and Fe are not known to have specific actions on the transcription of 
GABAB, Mn has been shown to bind to various forms of DNA structure, leading to conformational changes that 
might potentially affect the efficiency of gene transcription (Kennedy and Bryant, 1986). Protein expression of 
GABAB may also be attenuated through post-translational processes, such as recycling and degradation, 
mediated by regulatory kinases that may be affected by excess Mn. Decreases in both mRNA and protein 
expression of GABAB in hippocampus might indicate neuronal loss in that region as a result of Mn exposure 
(Sloot et al., 1994) as Mn has been shown to activate caspase-3 (Latchoumycandane et al., 2005), a mediator of 
apoptosis. A similar scenario might be the case in the substantia nigra. 
 
Decreases in GABAB expression due to Mn exposure and increased extracellular GABA may result in marked 
changes in behavior, particularly related to anxiety-like behaviors. GABAB deficient mice have ‘panic’ attacks 
and are more anxious in anxiety related behavioral screens (Mombereau et al., 2005). Similarly, GABAB 
knockout mice display spontaneous seizures, hyperalgesia, hyperlocomotion, and memory impairments (Emson, 
2007). Although both manganism and ID share many of these characteristics (Pal et al., 1999; Aschner et al., 
2005) with these mice models, it should be noted that changes in GABAA receptors might play a role. 
 
The change in mRNA expression in substantia nigra might represent interactions of Mn with DNA, causing a 
decrease in gene transcription efficiency (Hazell et al., 2003). The lack of changes in GABAA mRNA 
expression in the other regions suggests that the alterations observed in GABAA protein expression result from 
effects on post-translational processes. One possible mechanism for the increase seen in GABAA protein 
expression could be through increased trafficking of the receptor to the plasma membrane via phosphorylation 
of GABAA subunits by Akt (Wang et al., 2003) and since treatment of microglial cells with 500 μM Mn has 
been shown to activate Akt (Bae et al., 2006). 
 
The changes in protein and mRNA expression observed in the hippocampus and substantia nigra are 
particularly interesting given these two regions were observed to have the most impact from our dietary 
protocol. The hippocampus plays a vital role in memory and learning, with the majority of the neurons present 
in the hippocampus GABAergic (Gadea and López-Colomé, 2001). Manganese has also been shown to generate 
lesions in the hippocampus (Sloot et al., 1994) and impaired memory and learning scores have been observed in 
children exposed to high levels of manganese from the drinking water (Wasserman et al., 2006). The dramatic 
changes in expression of protein and mRNA levels in the substantia nigra, a region association with Parkinson’s 
disease and a target region for Mn accumulation (Aschner et al., 2005), lend credence to the hypothesis of a role 
for GABA in the effects on DA in this region during manganism. Recall that GABA neurons project from the 
striatum to the substantia nigra, inhibiting the dopaminergic output from the substantia nigra (Fig. 7). The 
differences in protein and mRNA expression observed in this study present a potential mechanism(s) to explain 
behaviors associated with Mn neurotoxicity. 
 
The novel results of this study illustrate the complex mechanisms involved in Mn neurotoxicity. The alterations 
observed in protein and mRNA expression of GABA receptor and transport proteins were not universal, with a 
diverse effect of Mn exposure on these two indices not only from region to region, but, in some cases, within 
the same region. Future studies to tease out the pathways involved in these shifts in expression are warranted. 
These alterations in receptor and transporter expression are important in light of the effects observed in animal 
models lacking GAT-1 (tremor and anxiety) and GABAB (anxiety and nervousness) (Emson, 2007; Chiu et al., 
2005; Mombereau et al., 2005), which are similar to symptoms of Mn neurotoxicity. Given the current findings, 
the increased levels of extracellular GABA in response to Mn exposure and ID are most likely due to decreased 
uptake of GABA rather than an increase in GABA release. Continuing studies in our lab will pharmacologically 
probe the effect of ID and Mn exposure on these extracellular GABA levels in order to fully understand the 
neurobiological consequences of Mn toxicity, especially as they relate to dietary exposures. 
 
References 
Ade KK, Janssen MJ, Ortinski PI, Vicini S. Differential tonic GABA conductances in striatal medium spiny 
neurons. J Neurosci 2008;28:1185–97. 
Anderson JG, Cooney PT, Erikson KM. Brain manganese accumulation is inversely related to GABA uptake in 
male and female rats. Tox Sci 2007a;95:188–95.  
Anderson JG, Cooney PT, Erikson KM. Inhibition of DAT function attenuates manganese accumulation in the 
globus pallidus. Environ Tox Pharmacol 2007b;23:179–84.  
Aschner M, Erikson KM, Dorman DC. Manganese dosimetry: species differences and implications for 
neurotoxicity. Crit Rev Tox 2005;35:1–32. 
Bae JH, Jang BC, Suh SI, Ha E, Baik HH, Kim SS, et al. Manganese induces inducible nitric oxide synthase 
(iNOS) expression via activation of both MAP kinase and PI3K/Akt pathways in BV2 microglial cells. 
Neurosci Lett 2006;398:151–4. 
Beard JL. Iron biology in immune function, muscle metabolism, and neuronal functioning. J Nutr 2001; 131: 
568s–79s. 
Beleboni RO, Carolino ROG, Pizzo AB, Castellan-Baldam L, Coutinho-Netto J, dos Santos WF, et al. 
Pharmacological and biochemical aspects of GABAergic neurotransmission: pathological and 
neuropsychobiological relationships. Cell Mol Neurobiol 2004;24:707–28. 
Burdo JR, Martin J, Menzies SL, Dolan KG, Romano MA, Fletcher RJ, et al. Cellular distribution of iron in the 
brain of the Belgrade rat. Neuroscience 1999;93:1189– 96. 
Carlsson M, Carlsson A. Interactions between glutamatergic and monoaminergic systems within the basal 
ganglia-implications for schizophrenia and Parkinson’s disease. Trends Neurosci 1990;13:272–6. 
Chandra SV, Shukla GS. Role of iron deficiency in inducing susceptibility to manganese toxicity. Arch Toxicol 
1976;35:319–23. 
Chen Z, Wu j, Baker GB, Parent M, Dovichi NJ. Application of capillary electrophoresis with laser-induced 
fluorescence detection to the determinations of biogenic amines and amino acids in brain microdialysate and 
homogenate samples. J Chromatogr A 2001;914:293–8. 
Chiu CS, Brickley S, Jensen K, Southwell A, McKinney S, Cull-Candy S, et al. GABA transporter deficiency 
causes tremor, ataxia, nervousness, and increased GABA-induced tonic conductance in cerebellum. J Neurosci 
2005;25:3234–45. 
Davis C, Wolf T, Greger J. Varying levels of manganese and iron affect absorption and gut endogenous losses 
of manganese by rats. J Nutr 1992;122:1300–8. 
Dickinson SD, Sabeti J, Larson GA, Giardina K, Rubinstein M, Kelly MA, et al. Dopamine D2 receptor-
deficient mice exhibit decreased dopamine transporter function but no changes in dopamine release in dorsal 
striatum. J Neurochem 1999;72:148–56. 
Emson PC. GABAB receptors: structure and function. Prog Brain Res 2007;160:43–57. 
Erikson KM, John CE, Jones SR, Aschner M. Manganese accumulation in striatum of mice exposed to toxic 
doses is dependent upon a functional dopamine transporter. Environ Toxicol Pharmacol 2005;20:390–4. 
Erikson KM, Syversen T, Steinnes E, Aschner M. Globus pallidus: a target brain region for divalent metal 
accumulation associated with dietary iron deficiency. J Nutr Biochem 2004;15:335–41. 
Erikson KM, Shihabi ZK, Aschner JL, Aschner M. Manganese accumulates in iron-deficient rat brain regions in 
a heterogeneous fashion and is associated with neurochemical alterations. Biolog Trace Elem Res 2002;87:143–
56. 
Erikson KM, Jones BC, Hess EJ, Zhang Q, Beard JL. Iron deficiency decreases dopamine D1 and D2 receptors 
in rat brain. Pharmacol Biochem Behav 2001;69:409–18.  
Erikson KM, Jones BC, Beard JL. Iron deficiency alters dopamine transporter functioning in rat striatum. J Nutr 
2000;130:2831–7. 
Expósito I, Del Arco A, Segovia G, Mora F. Endogenous dopamine increases extracellular concentrations of 
glutamate and GABA in striatum of the freely moving rat: involvement of D1 and D2 dopamine receptors. 
Neurochem Res 1999;24:849–56. 
Finley JW. Manganese absorption and retention by young women is associated with serum ferritin 
concentration. Am J Clin Nutr 1999;70:37–43. 
Gadea A, López-Colomé AM. Glial transporters for glutamate, glycine, and GABA: II. GABA transporters. J 
Neurosci Res 2001;63:461–8. 
Gainetdinov RR, Jones SR, Fumagalli F, Wightman RM, Caron MG. Re-evaluation of the role of the dopamine 
transporter in dopamine system homeostasis. Brain Res Rev 1998;26:148–53. 
Galindo A, Del Arco A, Mora F. Endogenous GABA potentiates the potassium-induced release of dopamine in 
striatum of the freely moving rat: a microdialysis study. Brain Res Bull 1999;50:209–14. 
Garcia SJ, Gellein K, Syversen T, Aschner M. A manganese enhanced diet alters brain metals and transporters 
in the developing rat. Tox Sci 2006;92:516–25. 
Garcia SJ, Gellein K, Syversen T, Aschner M. Iron deficient and manganese supplemented diets alter metals 
and transporters in the developing rat brain. Tox Sci 2007;95:205–14. 
Garrick MD, Dolan KG, Horbinski C, Ghio AJ, Higgins D, Porubcin M, et al. DMT1: a mammalian transporter 
for multiple metals. BioMetals 2003;16:41–54. 
Gether U, Andersen PH, Larsson EM, Schousboe A. Neurotransmitter transporters: molecular function of 
important drug targets. Trends Pharmacol Sci 2006;27: 375–83. 
Gunshin H, Allerson CR, Polycarpou-Schwarz M, Rofts A, Rogers JT, Kishi F, et al. Iron-dependent regulation 
of the divalent metal ion transporter. FEBS Lett 2001;509:309–16. 
Gunshin H, Mackenzie B, Berger UV, Gunshin Y, Romero MF, Boron WF, et al. Cloning and characterization 
of a mammalian proton-coupled metal transporter. Nature 1997;388:482–8. 
Gwiazda RH, Lee D, Sheridan J, Smith DR. Low cumulative manganese exposure affects striatal GABA but not 
dopamine. Neurotoxicology 2002;23:69–76. 
Hazell AS, Normandin L, Nguyen B, Kennedy G. Upregulation of ‘peripheral-type’ benzodiazepine receptors 
in the globus pallidus in a sub-acute rat model of manganese neurotoxicity. Neurosci Lett 2003;349:13–6. 
Hazell AS. Astrocytes and manganese neurotoxicity. Neurochem Int 2002;41:271–7. 
Hazell AS, Desjardins P, Butterworth RF. Chronic exposure of rat primary astrocyte cultures to manganese 
results in increased binding sites for the ‘peripheral-type’ benzodiazepine receptor ligand 3H-PK 11195. 
Neurosci Lett 1999;271:5–8. 
Hurley LS, Keen CL. Manganese. In: Underwood E, Mertz W, editors. Trace elements in human health and 
animal nutrition. New York, NY: Academic Press; 1987. p.185– 223. 
Ingersoll RT, Montgomery EB Jr, Aposhian HV. Central nervous system toxicity of manganese. II: Cocaine or 
reserpine inhibit manganese concentration in the rat brain. Neurotoxicology 1999;20:467–76. 
Kennedy SD, Bryant RG. Manganese-deoxyribonucleic acid binding modes. Nuclear magnetic relaxation 
dispersion results. Biophys J 1986;50:669–76. 
Kerr DIB, Ong J. GABAB receptors. Pharmac Ther 1995;67:187–246. 
Kondakis XG, Makris N, Leotsinidis M, Prinou M, Papapetropoulos T. Possible health effects of high 
manganese concentration in drinking water. Arch Environ Health 1989;44:175–8. 
Koo´s T, Tepper JM. Inhibitory control of neostriatal projection neurons by GABAergic interneurons. Nat 
Neurosci 1999;2:467–72. 
Kwik-Uribe CL, Golub MS, Keen CL. Chronic marginal iron intakes during early development in mice alter 
brain iron concentrations and behavior despite postnatal iron supplementation. J Nutr 2000;130:2040–8. 
Latchoumycandane C, Anantharam V, Kitazawa M, Yang Y, Kanthasamy A, Kanthasamy AG. Protein kinase 
C8 is a key downstream mediator of manganese-induced apoptosis in dopaminergic neuronal cells. J Pharmacol 
Exper Therap 2005;313: 46–55. 
Li D. Effects of iron deficiency on iron distribution and y-aminobutyric acid (GABA) metabolism in young rat 
brain tissues. Hokkaido J Med Sci 1998;73:215–25.  
Mandela P, Ordway GA. The norepinephrine transporter and its regulation. J Neurochem 2006;97:310–33. 
Mergler D, Huel G, Bowler R, Iregren A, Belanger S, Baldwin M, et al. Nervous system dysfunction among 
workers with long-term exposure to manganese. Environ Res 1994;64:151–80. 
Mombereau C, Kaupman K, Gassman M, Bettler B, van der Putten H, Cryan JF. Altered anxiety and 
depression-related behavior in mice lacking GABAB(2) receptor sub-units. Neuroreport 2005;16:307–10. 
Nelson C, Erikson KM, Piñero DJ, Beard JL. In vivo dopamine metabolism is altered in iron deficient anemic 
rats. J Nutr 1997;127:2282–8. 
Normandin L, Beaupre LA, Salehi F, St. Pierre A, Kennedy G, Mergler D, et al. Manganese distribution in the 
brain and neurobehavioral changes following inhalation expo-sure of rats to three chemical forms of 
manganese. Neurotoxicology 2004;25: 433–41. 
Olsen RW, DeLoreyTM. GABA and Glycine. In: Siegel GJ, Agranoff BW, Albers RW, Fisher SK, Uhler MD, 
editors. Basic Neurochemistry. Philadelphia: Lipincott Williams and Wilkins; 1999. p. 335–46. 
Pal PK, Samii A, Calne DB. Manganese neurotoxicity: a review of clinical features, imaging and pathology. 
Neurotoxicology 1999;20:227–38. 
Paxinos G, Watson C. The rat brain in stereotaxic coordinates. San Diego, CA: Academic Press Inc.; 1998. 
Powell PR, Ewing AG. Recent advances in the application of capillary electrophoresis to neuroscience. Anal 
Bioanal Chem 2005;382:581–91. 
Roth JA, Garrick MD. Iron interactions and other biological reactions mediating the physiological and toxic 
actions of manganese. Biochem Physiol 2003;66:1–13. 
Shukla A, Agarwal KN, Shukla GS. Latent iron deficiency alters gamma-aminobutyric acid and glutamate 
metabolism in rat brain. Experientia 1989;45:343–5. 
Shukla GS, Chandra SV, Seth PK. Effect of manganese on the levels of DNA, RNA, DNase and RNAse in 
cerebrum, cerebellum and rest of the brain regions of rat. Acta Pharmacol Toxicol (Copenhagen) 1976;39:562–
9. 
Sloot WN, van der Sluijs-Gelling AJ, Gramsbergen JBP. Selective lesions by manganese and extensive damage 
by iron after injection into rat striatum or hippocampus. J Neurochem 1994;62:205–16. 
Smith AD, Bolam JP. The neural network of the basal ganglia as revealed by the study of synaptic connections 
of identified neurons. Trends Neurosci 1990;13:259–65. 
Struve MF, McManus BE, Wong BA, Dorman DC. Basal ganglia neurotransmitter concentrations in Rhesus 
monkeys following subchronic manganese sulfate inhalation. Amer J Indust Med 2007;50:772–8. 
Vidal L, Alfonso M, Campos F, Faro LRF, Cervantes RC, Durin R. Effects of manganese on extracellular levels 
of dopamine in rat striatum: an analysis in vivo by brain microdialysis. Neurochem Res 2005;30:1147–54. 
Wang Q, Liu L, Pei L, Ju W, Ahmadian G, Lu J, et al. Control of synaptic strength, a novel function of Akt. 
Neuron 2003;38:915–28. 
Wasserman GA, Liu X, Parvez F, Ahsan H, Levy D, Factor-Litvak P, et al. Water manganese exposure and 
children’s intellectual function in Araihazar, Bangladesh. Environ Health Persp 2006;114:124–9. 
Zahniser NR, Doolen S. Chronic and acute regulation of Na+/Cl--dependent neuro-transmitter transporters: 
drugs, substrates, presynaptic receptors, and signaling systems. Pharmacol Therap 2001;92:21–55. 
